Innoviva (INVA) Operating Income Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1,386.07% |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn | -7.90% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.90% |
| Dec 31, 2025 | -31.16% |
| Sep 30, 2025 | -20.03% |
| Jun 30, 2025 | -10.85% |
| Mar 31, 2025 | 505.04% |
| Dec 31, 2024 | -60.22% |
| Sep 30, 2024 | -49.70% |
| Jun 30, 2024 | 667.93% |
| Mar 31, 2024 | 9.85% |
| Dec 31, 2023 | 36.31% |
| Sep 30, 2023 | 1,718,940.00% |
| Jun 30, 2023 | -4.44% |
| Mar 31, 2023 | -29.30% |
| Dec 31, 2022 | -70.77% |
| Sep 30, 2022 | -99.99% |
| Jun 30, 2022 | -109.55% |
| Mar 31, 2022 | -61.45% |
| Dec 31, 2021 | 6.28% |
| Sep 30, 2021 | 11.99% |
| Jun 30, 2021 | 27.38% |
| Mar 31, 2021 | -107.14% |
| Dec 31, 2020 | -108.76% |
| Sep 30, 2020 | 38.88% |
| Jun 30, 2020 | 26.83% |
| Mar 31, 2020 | 45.90% |
| Dec 31, 2019 | -4.64% |
| Sep 30, 2019 | 5.43% |
| Jun 30, 2019 | -4.65% |
| Mar 31, 2019 | 28.19% |
| Dec 31, 2018 | 16.28% |
| Sep 30, 2018 | 44.07% |
| Jun 30, 2018 | 31.04% |
| Mar 31, 2018 | 38.69% |
| Dec 31, 2017 | 76.33% |
| Sep 30, 2017 | 43.36% |
| Jun 30, 2017 | 84.84% |
| Mar 31, 2017 | 67.37% |
| Dec 31, 2016 | 117.78% |
| Sep 30, 2016 | 231.02% |
| Jun 30, 2016 | 406.60% |
| Mar 31, 2016 | 2,253.29% |
| Dec 31, 2015 | 13,202.31% |
| Sep 30, 2015 | 188.39% |
| Jun 30, 2015 | 152.15% |
| Mar 31, 2015 | 105.06% |
| Dec 31, 2014 | 101.75% |
| Sep 30, 2014 | -23.81% |
| Jun 30, 2014 | -41.98% |
| Mar 31, 2014 | 55.90% |
| Dec 31, 2013 | 82.39% |
| Sep 30, 2013 | 76.89% |
| Jun 30, 2013 | 80.68% |
| Mar 31, 2013 | -138.80% |
| Dec 31, 2012 | -18.42% |
| Sep 30, 2012 | -14.20% |
| Jun 30, 2012 | -50.94% |
| Mar 31, 2012 | 503.91% |
| Dec 31, 2011 | -98.38% |
| Sep 30, 2011 | -47.15% |
| Jun 30, 2011 | -21.74% |